Keybanc Maintains Overweight on ICU Medical, Raises Price Target to $180
Benzinga Newsdesk 8 months ago
NewsPrice TargetAnalyst Ratings
Keybanc analyst Brett Fishbin maintains ICU Medical (NASDAQ:ICUI) with a Overweight and raises the price target from $175 to $180.
Keybanc analyst Brett Fishbin maintains ICU Medical (NASDAQ:ICUI) with a Overweight and raises the price target from $175 to $180.